These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 11477100)

  • 41. Cyclopentenone prostaglandins induce lymphocyte apoptosis by activating the mitochondrial apoptosis pathway independent of external death receptor signaling.
    Nencioni A; Lauber K; Grünebach F; Van Parijs L; Denzlinger C; Wesselborg S; Brossart P
    J Immunol; 2003 Nov; 171(10):5148-56. PubMed ID: 14607914
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 15-deoxy-delta 12,14-prostaglandin J2 induces heme oxygenase-1 gene expression in a reactive oxygen species-dependent manner in human lymphocytes.
    Alvarez-Maqueda M; El Bekay R; Alba G; Monteseirín J; Chacón P; Vega A; Martín-Nieto J; Bedoya FJ; Pintado E; Sobrino F
    J Biol Chem; 2004 May; 279(21):21929-37. PubMed ID: 15024026
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
    Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
    Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PPARgamma is not required for the inhibitory actions of PGJ2 on cytokine signaling in pancreatic beta-cells.
    Weber SM; Scarim AL; Corbett JA
    Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E329-36. PubMed ID: 14600076
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
    Asano T; Wakisaka M; Yoshinari M; Iino K; Sonoki K; Iwase M; Fujishima M
    Biochim Biophys Acta; 2000 Jun; 1497(1):148-54. PubMed ID: 10838168
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes.
    Qin C; Morrow D; Stewart J; Spencer K; Porter W; Smith R; Phillips T; Abdelrahim M; Samudio I; Safe S
    Mol Cancer Ther; 2004 Mar; 3(3):247-60. PubMed ID: 15026545
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nonapoptotic cell death associated with S-phase arrest of prostate cancer cells via the peroxisome proliferator-activated receptor gamma ligand, 15-deoxy-delta12,14-prostaglandin J2.
    Butler R; Mitchell SH; Tindall DJ; Young CY
    Cell Growth Differ; 2000 Jan; 11(1):49-61. PubMed ID: 10672903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms.
    Cippitelli M; Fionda C; Di Bona D; Lupo A; Piccoli M; Frati L; Santoni A
    J Immunol; 2003 May; 170(9):4578-92. PubMed ID: 12707336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors.
    Fulzele SV; Chatterjee A; Shaik MS; Jackson T; Ichite N; Singh M
    Anticancer Drugs; 2007 Jan; 18(1):65-78. PubMed ID: 17159504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Peroxisome proliferator-activated receptor gamma is required for the inhibitory effect of ciglitazone but not 15-deoxy-Delta 12,14-prostaglandin J2 on the NFkappaB pathway in human endothelial cells.
    Kaplan J; Cook JA; O'Connor M; Zingarelli B
    Shock; 2007 Dec; 28(6):722-726. PubMed ID: 17621259
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 15-Deoxy-Delta(12,14)-prostaglandin J2 induces IL-8 and GM-CSF in a human airway epithelial cell line (NCI-H292).
    Chiba T; Ueki S; Ito W; Kato H; Takeda M; Kayaba H; Furue M; Chihara J
    Int Arch Allergy Immunol; 2009; 149 Suppl 1():77-82. PubMed ID: 19494510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 15-Deoxy-Δ12,14-prostaglandin J2 induces expression of 15-hydroxyprostaglandin dehydrogenase through Elk-1 activation in human breast cancer MDA-MB-231 cells.
    Kim HR; Lee HN; Lim K; Surh YJ; Na HK
    Mutat Res; 2014 Oct; 768():6-15. PubMed ID: 25773924
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; Iñiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
    Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The 15-deoxy-delta12,14-prostaglandin J2 inhibits the inflammatory response in primary rat astrocytes via down-regulating multiple steps in phosphatidylinositol 3-kinase-Akt-NF-kappaB-p300 pathway independent of peroxisome proliferator-activated receptor gamma.
    Giri S; Rattan R; Singh AK; Singh I
    J Immunol; 2004 Oct; 173(8):5196-208. PubMed ID: 15470065
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 15-Deoxy-Δ(12,14)-prostaglandin J2 prevents oxidative injury by upregulating the expression of aldose reductase in vascular smooth muscle cells.
    Kang ES; Hwang JS; Ham SA; Park MH; Kim GH; Paek KS; Yoo T; Lee WJ; Kang KR; Lee JH; Choi YJ; Seo HG
    Free Radic Res; 2014 Feb; 48(2):218-29. PubMed ID: 24180671
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glutathione S-transferases (GSTs) inhibit transcriptional activation by the peroxisomal proliferator-activated receptor gamma (PPAR gamma) ligand, 15-deoxy-delta 12,14prostaglandin J2 (15-d-PGJ2).
    Paumi CM; Smitherman PK; Townsend AJ; Morrow CS
    Biochemistry; 2004 Mar; 43(8):2345-52. PubMed ID: 14979731
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.
    Kliewer SA; Lenhard JM; Willson TM; Patel I; Morris DC; Lehmann JM
    Cell; 1995 Dec; 83(5):813-9. PubMed ID: 8521498
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heme oxygenase-1 is an antifibrogenic protein in human hepatic myofibroblasts.
    Li L; Grenard P; Nhieu JT; Julien B; Mallat A; Habib A; Lotersztajn S
    Gastroenterology; 2003 Aug; 125(2):460-9. PubMed ID: 12891549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential regulation of chemokine gene expression by 15-deoxy-delta 12,14 prostaglandin J2.
    Zhang X; Wang JM; Gong WH; Mukaida N; Young HA
    J Immunol; 2001 Jun; 166(12):7104-11. PubMed ID: 11390455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.